Analyzing the options chain and the chart patterns of BTAI BioXcel Therapeutics prior to the earnings report this week, I would consider purchasing the 3usd strike price Calls with an expiration date of 2024-3-15, for a premium of approximately $0.25. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
NASDAQ:BTAI Technical Analysis for NASDAQ:BTAI : If the price of BTAI breaks above the bullish line of $11.61, it may indicate a bullish signal, suggesting potential upward price movement. In this scenario, the target price could be set at $16.80. Conversely, if the price of BTAI breaks below the bearish line of $8.80, it may suggest a bearish signal,...
$BTAI Target 42.51 for 47.09% Or next add at 23.79 There is a bullish RSI divergence on the daily chart... I'd like to see this hold above that trendline... Just looking at indicators... if it holds I might even add a little more tomorrow for the ride up... ----- — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level...
$BTAI Target 37.60 for 30.1% Or double position at 20.20 I took this one earlier today… @28.90… Let’s see what happens… — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as...
BTAI has just broken out of a nice bullish symmetrical triangle formation. As you can see from my chart the breakout was backed by strong volume as it occurred at a significantly higher level of volume than seen during the consolidation phase. Now that the breakout has occurred you can also see my GMMA oscillator is dying to cross over into the green. The last and...
BTAI has same promising setup. It has retraced 61.8% of the recent upmove and is poised to launch a lot higher. Good risk/reward long here.
$BTAI should see a major breakout above $12. The risk/reward setup looks promising. About BioXcel Therapeutics, Inc.: BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence approaches to identify and advance the next wave of medicines in neuroscience and immuno-oncology....
Watch My Video Analysis By Clicking The Link Below!